MDxHealth SA reports results for the quarter ended March 31 - Earnings Summary
14/05/2025 22:01
MDxHealth SA MDXH.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -31 cents. The mean expectation of five analysts for the quarter was for a loss of 13 cents per share. Wall Street expected results to range from -15 cents to -12 cents per share. Revenue rose 22.5% to $24.29 million from a year ago; analysts expected $24.07 million. MDxHealth SA's reported EPS for the quarter was a loss of 19 cents. The company reported a quarterly loss of $9.21 million. MDxHealth SA shares had risen by 25.4% this quarter and lost 24.9% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 27.8% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." Wall Street's median 12-month price target for MDxHealth SA is $6.00 This summary was machine generated from LSEG data May 14 at 09:00 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Mar. 31 2025 | -0.13 | -0.19 | Missed |
| Dec. 31 2024 | -0.19 | -0.14 | Beat |
| Sep. 30 2024 | -0.27 | -0.40 | Missed |
| Jun. 30 2024 | -0.26 | -0.42 | Missed |